|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-12-16
|
|
pubmed:abstractText |
Voriconazole is used to manage invasive fungal diseases in recipients of an allogeneic haematopoietic stem cell transplant (HSCT) after myeloablative treatment. Little is known about the pharmacokinetics (PK) of voriconazole in this population, who also receive cyclosporine A.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1460-2091
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
107-13
|
|
pubmed:meshHeading |
pubmed-meshheading:19933691-Adolescent,
pubmed-meshheading:19933691-Adult,
pubmed-meshheading:19933691-Aged,
pubmed-meshheading:19933691-Antifungal Agents,
pubmed-meshheading:19933691-Blood Chemical Analysis,
pubmed-meshheading:19933691-Cyclosporine,
pubmed-meshheading:19933691-Female,
pubmed-meshheading:19933691-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:19933691-Humans,
pubmed-meshheading:19933691-Infusions, Intravenous,
pubmed-meshheading:19933691-Male,
pubmed-meshheading:19933691-Metabolic Clearance Rate,
pubmed-meshheading:19933691-Middle Aged,
pubmed-meshheading:19933691-Mycoses,
pubmed-meshheading:19933691-Pyrimidines,
pubmed-meshheading:19933691-Transplantation,
pubmed-meshheading:19933691-Transplantation, Homologous,
pubmed-meshheading:19933691-Triazoles,
pubmed-meshheading:19933691-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
|
|
pubmed:affiliation |
Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
